| 49:1.0.1.1.30.1 | SUBPART A
| Subpart A - Administrative Provisions | |
| 49:1.0.1.1.30.1.43.1 | SECTION 40.1
| 40.1 Who does this regulation cover | |
| 49:1.0.1.1.30.1.43.2 | SECTION 40.3
| 40.3 What do the terms used in this part mean | |
| 49:1.0.1.1.30.1.43.3 | SECTION 40.5
| 40.5 Who issues authoritative interpretations of this regulation | |
| 49:1.0.1.1.30.1.43.4 | SECTION 40.7
| 40.7 How can you get an exemption from a requirement in this regulation | |
| 49:1.0.1.1.30.2 | SUBPART B
| Subpart B - Employer Responsibilities | |
| 49:1.0.1.1.30.2.43.1 | SECTION 40.11
| 40.11 What are the general responsibilities of employers under this regulation | |
| 49:1.0.1.1.30.2.43.2 | SECTION 40.13
| 40.13 How do DOT drug and alcohol tests relate to non-DOT tests | |
| 49:1.0.1.1.30.2.43.3 | SECTION 40.14
| 40.14 What collection information must employers provide to collectors | |
| 49:1.0.1.1.30.2.43.4 | SECTION 40.15
| 40.15 May an employer use a service agent to meet DOT drug and alcohol testing requirements | |
| 49:1.0.1.1.30.2.43.5 | SECTION 40.17
| 40.17 Is an employer responsible for obtaining information from its service agents | |
| 49:1.0.1.1.30.2.43.6 | SECTION 40.19
| 40.19 [Reserved] | |
| 49:1.0.1.1.30.2.43.7 | SECTION 40.21
| 40.21 May an employer stand down an employee before the MRO has completed the verification process | |
| 49:1.0.1.1.30.2.43.8 | SECTION 40.23
| 40.23 What actions do employers take after receiving verified test results | |
| 49:1.0.1.1.30.2.43.9 | SECTION 40.25
| 40.25 Must an employer check on the drug and alcohol testing record of employees it is intending to use to perform safety-sensitive duties | |
| 49:1.0.1.1.30.2.43.10 | SECTION 40.26
| 40.26 What form must an employer use to report Management Information System (MIS) data to a DOT agency | |
| 49:1.0.1.1.30.2.43.11 | SECTION 40.27
| 40.27 May an employer require an employee to sign a consent or release in connection with the DOT drug and alcohol testing program | |
| 49:1.0.1.1.30.2.43.12 | SECTION 40.29
| 40.29 Where is other information on employer responsibilities found in this regulation | |
| 49:1.0.1.1.30.3 | SUBPART C
| Subpart C - Urine Collection Personnel | |
| 49:1.0.1.1.30.3.43.1 | SECTION 40.31
| 40.31 Who may collect urine specimens for DOT drug testing | |
| 49:1.0.1.1.30.3.43.2 | SECTION 40.33
| 40.33 What training requirements must a collector meet | |
| 49:1.0.1.1.30.3.43.3 | SECTION 40.35
| 40.35 What information about the DER must employers provide to collectors | |
| 49:1.0.1.1.30.3.43.4 | SECTION 40.37
| 40.37 Where is other information on the role of collectors found in this regulation | |
| 49:1.0.1.1.30.4 | SUBPART D
| Subpart D - Collection Sites, Forms, Equipment and Supplies Used in DOT Urine Collections | |
| 49:1.0.1.1.30.4.43.1 | SECTION 40.41
| 40.41 Where does a urine collection for a DOT drug test take place | |
| 49:1.0.1.1.30.4.43.2 | SECTION 40.43
| 40.43 What steps must operators of collection sites take to protect the security and integrity of urine collections | |
| 49:1.0.1.1.30.4.43.3 | SECTION 40.45
| 40.45 What form is used to document a DOT urine collection | |
| 49:1.0.1.1.30.4.43.4 | SECTION 40.47
| 40.47 May employers use the CCF for non-Federal collections or non-Federal forms for DOT collections | |
| 49:1.0.1.1.30.4.43.5 | SECTION 40.49
| 40.49 What materials are used to collect urine specimens | |
| 49:1.0.1.1.30.4.43.6 | SECTION 40.51
| 40.51 What materials are used to send urine specimens to the laboratory | |
| 49:1.0.1.1.30.5 | SUBPART E
| Subpart E - Urine Specimen Collections | |
| 49:1.0.1.1.30.5.43.1 | SECTION 40.61
| 40.61 What are the preliminary steps in the collection process | |
| 49:1.0.1.1.30.5.43.2 | SECTION 40.63
| 40.63 What steps does the collector take in the collection process before the employee provides a urine specimen | |
| 49:1.0.1.1.30.5.43.3 | SECTION 40.65
| 40.65 What does the collector check for when the employee presents a specimen | |
| 49:1.0.1.1.30.5.43.4 | SECTION 40.67
| 40.67 When and how is a directly observed collection conducted | |
| 49:1.0.1.1.30.5.43.5 | SECTION 40.69
| 40.69 How is a monitored collection conducted | |
| 49:1.0.1.1.30.5.43.6 | SECTION 40.71
| 40.71 How does the collector prepare the specimens | |
| 49:1.0.1.1.30.5.43.7 | SECTION 40.73
| 40.73 How is the collection process completed | |
| 49:1.0.1.1.30.6 | SUBPART F
| Subpart F - Drug Testing Laboratories | |
| 49:1.0.1.1.30.6.43.1 | SECTION 40.81
| 40.81 What laboratories may be used for DOT drug testing | |
| 49:1.0.1.1.30.6.43.2 | SECTION 40.83
| 40.83 How do laboratories process incoming specimens | |
| 49:1.0.1.1.30.6.43.3 | SECTION 40.85
| 40.85 What drugs do laboratories test for | |
| 49:1.0.1.1.30.6.43.4 | SECTION 40.87
| 40.87 What are the cutoff concentrations for drug tests | |
| 49:1.0.1.1.30.6.43.5 | SECTION 40.89
| 40.89 What is validity testing, and are laboratories required to conduct it | |
| 49:1.0.1.1.30.6.43.6 | SECTION 40.91
| 40.91 What validity tests must laboratories conduct on primary specimens | |
| 49:1.0.1.1.30.6.43.7 | SECTION 40.93
| 40.93 What criteria do laboratories use to establish that a specimen is dilute or substituted | |
| 49:1.0.1.1.30.6.43.8 | SECTION 40.95
| 40.95 What are the adulterant cutoff concentrations for initial and confirmation tests | |
| 49:1.0.1.1.30.6.43.9 | SECTION 40.96
| 40.96 What criteria do laboratories use to establish that a specimen is invalid | |
| 49:1.0.1.1.30.6.43.10 | SECTION 40.97
| 40.97 What do laboratories report and how do they report it | |
| 49:1.0.1.1.30.6.43.11 | SECTION 40.99
| 40.99 How long does the laboratory retain specimens after testing | |
| 49:1.0.1.1.30.6.43.12 | SECTION 40.101
| 40.101 What relationship may a laboratory have with an MRO | |
| 49:1.0.1.1.30.6.43.13 | SECTION 40.107
| 40.107 Who may inspect laboratories | |
| 49:1.0.1.1.30.6.43.14 | SECTION 40.109
| 40.109 What documentation must the laboratory keep, and for how long | |
| 49:1.0.1.1.30.6.43.15 | SECTION 40.111
| 40.111 When and how must a laboratory disclose statistical summaries and other information it maintains | |
| 49:1.0.1.1.30.6.43.16 | SECTION 40.113
| 40.113 Where is other information concerning laboratories found in this regulation | |
| 49:1.0.1.1.30.7 | SUBPART G
| Subpart G - Medical Review Officers and the Verification Process | |
| 49:1.0.1.1.30.7.43.1 | SECTION 40.121
| 40.121 Who is qualified to act as an MRO | |
| 49:1.0.1.1.30.7.43.2 | SECTION 40.123
| 40.123 What are the MRO's responsibilities in the DOT drug testing program | |
| 49:1.0.1.1.30.7.43.3 | SECTION 40.125
| 40.125 What relationship may an MRO have with a laboratory | |
| 49:1.0.1.1.30.7.43.4 | SECTION 40.127
| 40.127 What are the MRO's functions in reviewing negative test results | |
| 49:1.0.1.1.30.7.43.5 | SECTION 40.129
| 40.129 What are the MRO's functions in reviewing laboratory confirmed non-negative drug test results | |
| 49:1.0.1.1.30.7.43.6 | SECTION 40.131
| 40.131 How does the MRO or DER notify an employee of the verification process after receiving laboratory confirmed non-negative drug test results | |
| 49:1.0.1.1.30.7.43.7 | SECTION 40.133
| 40.133 Without interviewing the employee, under what circumstances may the MRO verify a test result as positive, or as a refusal to test because of adulteration or substitution, or as cancelled because the test was invalid | |
| 49:1.0.1.1.30.7.43.8 | SECTION 40.135
| 40.135 What does the MRO tell the employee at the beginning of the verification interview | |
| 49:1.0.1.1.30.7.43.9 | SECTION 40.137
| 40.137 On what basis does the MRO verify test results involving marijuana, cocaine, amphetamines, semi-synthetic opioids, or PCP | |
| 49:1.0.1.1.30.7.43.10 | SECTION 40.139
| 40.139 On what basis does the MRO verify test results involving 6-acetylmorphine, codeine, and morphine | |
| 49:1.0.1.1.30.7.43.11 | SECTION 40.141
| 40.141 How does the MRO obtain information for the verification decision | |
| 49:1.0.1.1.30.7.43.12 | SECTION 40.143
| 40.143 [Reserved] | |
| 49:1.0.1.1.30.7.43.13 | SECTION 40.145
| 40.145 On what basis does the MRO verify test results involving adulteration or substitution | |
| 49:1.0.1.1.30.7.43.14 | SECTION 40.147
| 40.147 [Reserved] | |
| 49:1.0.1.1.30.7.43.15 | SECTION 40.149
| 40.149 May the MRO change a verified drug test result | |
| 49:1.0.1.1.30.7.43.16 | SECTION 40.151
| 40.151 What are MROs prohibited from doing as part of the verification process | |
| 49:1.0.1.1.30.7.43.17 | SECTION 40.153
| 40.153 How does the MRO notify employees of their right to a test of the split specimen | |
| 49:1.0.1.1.30.7.43.18 | SECTION 40.155
| 40.155 What does the MRO do when a negative or positive test result is also dilute | |
| 49:1.0.1.1.30.7.43.19 | SECTION 40.157
| 40.157 [Reserved] | |
| 49:1.0.1.1.30.7.43.20 | SECTION 40.159
| 40.159 What does the MRO do when a drug test result is invalid | |
| 49:1.0.1.1.30.7.43.21 | SECTION 40.160
| 40.160 What does the MRO do when a valid test result cannot be produced and a negative result is required | |
| 49:1.0.1.1.30.7.43.22 | SECTION 40.161
| 40.161 What does the MRO do when a drug test specimen is rejected for testing | |
| 49:1.0.1.1.30.7.43.23 | SECTION 40.162
| 40.162 What must MROs do with multiple verified results for the same testing event | |
| 49:1.0.1.1.30.7.43.24 | SECTION 40.163
| 40.163 How does the MRO report drug test results | |
| 49:1.0.1.1.30.7.43.25 | SECTION 40.165
| 40.165 To whom does the MRO transmit reports of drug test results | |
| 49:1.0.1.1.30.7.43.26 | SECTION 40.167
| 40.167 How are MRO reports of drug results transmitted to the employer | |
| 49:1.0.1.1.30.7.43.27 | SECTION 40.169
| 40.169 Where is other information concerning the role of MROs and the verification process found in this regulation | |
| 49:1.0.1.1.30.8 | SUBPART H
| Subpart H - Split Specimen Tests | |
| 49:1.0.1.1.30.8.43.1 | SECTION 40.171
| 40.171 How does an employee request a test of a split specimen | |
| 49:1.0.1.1.30.8.43.2 | SECTION 40.173
| 40.173 Who is responsible for paying for the test of a split specimen | |
| 49:1.0.1.1.30.8.43.3 | SECTION 40.175
| 40.175 What steps does the first laboratory take with a split specimen | |
| 49:1.0.1.1.30.8.43.4 | SECTION 40.177
| 40.177 What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite | |
| 49:1.0.1.1.30.8.43.5 | SECTION 40.179
| 40.179 What does the second laboratory do with the split specimen when it is tested to reconfirm an adulterated test result | |
| 49:1.0.1.1.30.8.43.6 | SECTION 40.181
| 40.181 What does the second laboratory do with the split specimen when it is tested to reconfirm a substituted test result | |
| 49:1.0.1.1.30.8.43.7 | SECTION 40.183
| 40.183 What information do laboratories report to MROs regarding split specimen results | |
| 49:1.0.1.1.30.8.43.8 | SECTION 40.185
| 40.185 Through what methods and to whom must a laboratory report split specimen results | |
| 49:1.0.1.1.30.8.43.9 | SECTION 40.187
| 40.187 What does the MRO do with split specimen laboratory results | |
| 49:1.0.1.1.30.8.43.10 | SECTION 40.189
| 40.189 Where is other information concerning split specimens found in this regulation | |
| 49:1.0.1.1.30.9 | SUBPART I
| Subpart I - Problems in Drug Tests | |
| 49:1.0.1.1.30.9.43.1 | SECTION 40.191
| 40.191 What is a refusal to take a DOT drug test, and what are the consequences | |
| 49:1.0.1.1.30.9.43.2 | SECTION 40.193
| 40.193 What happens when an employee does not provide a sufficient amount of urine for a drug test | |
| 49:1.0.1.1.30.9.43.3 | SECTION 40.195
| 40.195 What happens when an individual is unable to provide a sufficient amount of urine for a pre-employment follow-up or return-to-duty test because of a permanent or long-term medical condition | |
| 49:1.0.1.1.30.9.43.4 | SECTION 40.197
| 40.197 What happens when an employer receives a report of a dilute specimen | |
| 49:1.0.1.1.30.9.43.5 | SECTION 40.199
| 40.199 What problems always cause a drug test to be cancelled | |
| 49:1.0.1.1.30.9.43.6 | SECTION 40.201
| 40.201 What problems always cause a drug test to be cancelled and may result in a requirement for another collection | |
| 49:1.0.1.1.30.9.43.7 | SECTION 40.203
| 40.203 What problems cause a drug test to be cancelled unless they are corrected | |
| 49:1.0.1.1.30.9.43.8 | SECTION 40.205
| 40.205 How are drug test problems corrected | |
| 49:1.0.1.1.30.9.43.9 | SECTION 40.207
| 40.207 What is the effect of a cancelled drug test | |
| 49:1.0.1.1.30.9.43.10 | SECTION 40.208
| 40.208 What problem requires corrective action but does not result in the cancellation of a test | |
| 49:1.0.1.1.30.9.43.11 | SECTION 40.209
| 40.209 What procedural problems do not result in the cancellation of a test and do not require correction | |
| 49:1.0.1.1.30.9.43.12 | SECTION 40.210
| 40.210 Are drug tests other than urine permitted under the regulations | |
| 49:1.0.1.1.30.10 | SUBPART J
| Subpart J - Alcohol Testing Personnel | |
| 49:1.0.1.1.30.10.43.1 | SECTION 40.211
| 40.211 Who conducts DOT alcohol tests | |
| 49:1.0.1.1.30.10.43.2 | SECTION 40.213
| 40.213 What training requirements must STTs and BATs meet | |
| 49:1.0.1.1.30.10.43.3 | SECTION 40.215
| 40.215 What information about the DER do employers have to provide to BATs and STTs | |
| 49:1.0.1.1.30.10.43.4 | SECTION 40.217
| 40.217 Where is other information on the role of STTs and BATs found in this regulation | |
| 49:1.0.1.1.30.11 | SUBPART K
| Subpart K - Testing Sites, Forms, Equipment and Supplies Used in Alcohol Testing | |
| 49:1.0.1.1.30.11.43.1 | SECTION 40.221
| 40.221 Where does an alcohol test take place | |
| 49:1.0.1.1.30.11.43.2 | SECTION 40.223
| 40.223 What steps must be taken to protect the security of alcohol testing sites | |
| 49:1.0.1.1.30.11.43.3 | SECTION 40.225
| 40.225 What form is used for an alcohol test | |
| 49:1.0.1.1.30.11.43.4 | SECTION 40.227
| 40.227 May employers use the ATF for non-DOT tests, or non-DOT forms for DOT tests | |
| 49:1.0.1.1.30.11.43.5 | SECTION 40.229
| 40.229 What devices are used to conduct alcohol screening tests | |
| 49:1.0.1.1.30.11.43.6 | SECTION 40.231
| 40.231 What devices are used to conduct alcohol confirmation tests | |
| 49:1.0.1.1.30.11.43.7 | SECTION 40.233
| 40.233 What are the requirements for proper use and care of EBTs | |
| 49:1.0.1.1.30.11.43.8 | SECTION 40.235
| 40.235 What are the requirements for proper use and care of ASDs | |
| 49:1.0.1.1.30.12 | SUBPART L
| Subpart L - Alcohol Screening Tests | |
| 49:1.0.1.1.30.12.43.1 | SECTION 40.241
| 40.241 What are the first steps in any alcohol screening test | |
| 49:1.0.1.1.30.12.43.2 | SECTION 40.243
| 40.243 What is the procedure for an alcohol screening test using an EBT or non-evidential breath ASD | |
| 49:1.0.1.1.30.12.43.3 | SECTION 40.245
| 40.245 What is the procedure for an alcohol screening test using a saliva ASD or a breath tube ASD | |
| 49:1.0.1.1.30.12.43.4 | SECTION 40.247
| 40.247 What procedures does the BAT or STT follow after a screening test result | |
| 49:1.0.1.1.30.13 | SUBPART M
| Subpart M - Alcohol Confirmation Tests | |
| 49:1.0.1.1.30.13.43.1 | SECTION 40.251
| 40.251 What are the first steps in an alcohol confirmation test | |
| 49:1.0.1.1.30.13.43.2 | SECTION 40.253
| 40.253 What are the procedures for conducting an alcohol confirmation test | |
| 49:1.0.1.1.30.13.43.3 | SECTION 40.255
| 40.255 What happens next after the alcohol confirmation test result | |
| 49:1.0.1.1.30.14 | SUBPART N
| Subpart N - Problems in Alcohol Testing | |
| 49:1.0.1.1.30.14.43.1 | SECTION 40.261
| 40.261 What is a refusal to take an alcohol test, and what are the consequences | |
| 49:1.0.1.1.30.14.43.2 | SECTION 40.263
| 40.263 What happens when an employee is unable to provide a sufficient amount of saliva for an alcohol screening test | |
| 49:1.0.1.1.30.14.43.3 | SECTION 40.265
| 40.265 What happens when an employee is unable to provide a sufficient amount of breath for an alcohol test | |
| 49:1.0.1.1.30.14.43.4 | SECTION 40.267
| 40.267 What problems always cause an alcohol test to be cancelled | |
| 49:1.0.1.1.30.14.43.5 | SECTION 40.269
| 40.269 What problems cause an alcohol test to be cancelled unless they are corrected | |
| 49:1.0.1.1.30.14.43.6 | SECTION 40.271
| 40.271 How are alcohol testing problems corrected | |
| 49:1.0.1.1.30.14.43.7 | SECTION 40.273
| 40.273 What is the effect of a cancelled alcohol test | |
| 49:1.0.1.1.30.14.43.8 | SECTION 40.275
| 40.275 What is the effect of procedural problems that are not sufficient to cancel an alcohol test | |
| 49:1.0.1.1.30.14.43.9 | SECTION 40.277
| 40.277 Are alcohol tests other than saliva or breath permitted under these regulations | |
| 49:1.0.1.1.30.15 | SUBPART O
| Subpart O - Substance Abuse Professionals and the Return-to-Duty Process | |
| 49:1.0.1.1.30.15.43.1 | SECTION 40.281
| 40.281 Who is qualified to act as a SAP | |
| 49:1.0.1.1.30.15.43.2 | SECTION 40.283
| 40.283 How does a certification organization obtain recognition for its members as SAPs | |
| 49:1.0.1.1.30.15.43.3 | SECTION 40.285
| 40.285 When is a SAP evaluation required | |
| 49:1.0.1.1.30.15.43.4 | SECTION 40.287
| 40.287 What information is an employer required to provide concerning SAP services to an employee who has a DOT drug and alcohol regulation violation | |
| 49:1.0.1.1.30.15.43.5 | SECTION 40.289
| 40.289 Are employers required to provide SAP and treatment services to employees | |
| 49:1.0.1.1.30.15.43.6 | SECTION 40.291
| 40.291 What is the role of the SAP in the evaluation, referral, and treatment process of an employee who has violated DOT agency drug and alcohol testing regulations | |
| 49:1.0.1.1.30.15.43.7 | SECTION 40.293
| 40.293 What is the SAP's function in conducting the initial evaluation of an employee | |
| 49:1.0.1.1.30.15.43.8 | SECTION 40.295
| 40.295 May employees or employers seek a second SAP evaluation if they disagree with the first SAP's recommendations | |
| 49:1.0.1.1.30.15.43.9 | SECTION 40.297
| 40.297 Does anyone have the authority to change a SAP's initial evaluation | |
| 49:1.0.1.1.30.15.43.10 | SECTION 40.299
| 40.299 What is the SAP's role and what are the limits on a SAP's discretion in referring employees for education and treatment | |
| 49:1.0.1.1.30.15.43.11 | SECTION 40.301
| 40.301 What is the SAP's function in the follow-up evaluation of an employee | |
| 49:1.0.1.1.30.15.43.12 | SECTION 40.303
| 40.303 What happens if the SAP believes the employee needs additional treatment, aftercare, or support group services even after the employee returns to safety-sensitive duties | |
| 49:1.0.1.1.30.15.43.13 | SECTION 40.305
| 40.305 How does the return-to-duty process conclude | |
| 49:1.0.1.1.30.15.43.14 | SECTION 40.307
| 40.307 What is the SAP's function in prescribing the employee's follow-up tests | |
| 49:1.0.1.1.30.15.43.15 | SECTION 40.309
| 40.309 What are the employer's responsibilities with respect to the SAP's directions for follow-up tests | |
| 49:1.0.1.1.30.15.43.16 | SECTION 40.311
| 40.311 What are the requirements concerning SAP reports | |
| 49:1.0.1.1.30.15.43.17 | SECTION 40.313
| 40.313 Where is other information on SAP functions and the return-to-duty process found in this regulation | |
| 49:1.0.1.1.30.16 | SUBPART P
| Subpart P - Confidentiality and Release of Information | |
| 49:1.0.1.1.30.16.43.1 | SECTION 40.321
| 40.321 What is the general confidentiality rule for drug and alcohol test information | |
| 49:1.0.1.1.30.16.43.2 | SECTION 40.323
| 40.323 May program participants release drug or alcohol test information in connection with legal proceedings | |
| 49:1.0.1.1.30.16.43.3 | SECTION 40.325
| 40.325 [Reserved] | |
| 49:1.0.1.1.30.16.43.4 | SECTION 40.327
| 40.327 When must the MRO report medical information gathered in the verification process | |
| 49:1.0.1.1.30.16.43.5 | SECTION 40.329
| 40.329 What information must laboratories, MROs, and other service agents release to employees | |
| 49:1.0.1.1.30.16.43.6 | SECTION 40.331
| 40.331 To what additional parties must employers and service agents release information | |
| 49:1.0.1.1.30.16.43.7 | SECTION 40.333
| 40.333 What records must employers keep | |
| 49:1.0.1.1.30.17 | SUBPART Q
| Subpart Q - Roles and Responsibilities of Service Agents | |
| 49:1.0.1.1.30.17.43.1 | SECTION 40.341
| 40.341 Must service agents comply with DOT drug and alcohol testing requirements | |
| 49:1.0.1.1.30.17.43.2 | SECTION 40.343
| 40.343 What tasks may a service agent perform for an employer | |
| 49:1.0.1.1.30.17.43.3 | SECTION 40.345
| 40.345 In what circumstances may a C/TPA act as an intermediary in the transmission of drug and alcohol testing information to employers | |
| 49:1.0.1.1.30.17.43.4 | SECTION 40.347
| 40.347 What functions may C/TPAs perform with respect to administering testing | |
| 49:1.0.1.1.30.17.43.5 | SECTION 40.349
| 40.349 What records may a service agent receive and maintain | |
| 49:1.0.1.1.30.17.43.6 | SECTION 40.351
| 40.351 What confidentiality requirements apply to service agents | |
| 49:1.0.1.1.30.17.43.7 | SECTION 40.353
| 40.353 What principles govern the interaction between MROs and other service agents | |
| 49:1.0.1.1.30.17.43.8 | SECTION 40.355
| 40.355 What limitations apply to the activities of service agents | |
| 49:1.0.1.1.30.18 | SUBPART R
| Subpart R - Public Interest Exclusions | |
| 49:1.0.1.1.30.18.43.1 | SECTION 40.361
| 40.361 What is the purpose of a public interest exclusion (PIE) | |
| 49:1.0.1.1.30.18.43.2 | SECTION 40.363
| 40.363 On what basis may the Department issue a PIE | |
| 49:1.0.1.1.30.18.43.3 | SECTION 40.365
| 40.365 What is the Department's policy concerning starting a PIE proceeding | |
| 49:1.0.1.1.30.18.43.4 | SECTION 40.367
| 40.367 Who initiates a PIE proceeding | |
| 49:1.0.1.1.30.18.43.5 | SECTION 40.369
| 40.369 What is the discretion of an initiating official in starting a PIE proceeding | |
| 49:1.0.1.1.30.18.43.6 | SECTION 40.371
| 40.371 On what information does an initiating official rely in deciding whether to start a PIE proceeding | |
| 49:1.0.1.1.30.18.43.7 | SECTION 40.373
| 40.373 Before starting a PIE proceeding, does the initiating official give the service agent an opportunity to correct problems | |
| 49:1.0.1.1.30.18.43.8 | SECTION 40.375
| 40.375 How does the initiating official start a PIE proceeding | |
| 49:1.0.1.1.30.18.43.9 | SECTION 40.377
| 40.377 Who decides whether to issue a PIE | |
| 49:1.0.1.1.30.18.43.10 | SECTION 40.379
| 40.379 How do you contest the issuance of a PIE | |
| 49:1.0.1.1.30.18.43.11 | SECTION 40.381
| 40.381 What information do you present to contest the proposed issuance of a PIE | |
| 49:1.0.1.1.30.18.43.12 | SECTION 40.383
| 40.383 What procedures apply if you contest the issuance of a PIE | |
| 49:1.0.1.1.30.18.43.13 | SECTION 40.385
| 40.385 Who bears the burden of proof in a PIE proceeding | |
| 49:1.0.1.1.30.18.43.14 | SECTION 40.387
| 40.387 What matters does the Director decide concerning a proposed PIE | |
| 49:1.0.1.1.30.18.43.15 | SECTION 40.389
| 40.389 What factors may the Director consider | |
| 49:1.0.1.1.30.18.43.16 | SECTION 40.391
| 40.391 What is the scope of a PIE | |
| 49:1.0.1.1.30.18.43.17 | SECTION 40.393
| 40.393 How long does a PIE stay in effect | |
| 49:1.0.1.1.30.18.43.18 | SECTION 40.395
| 40.395 Can you settle a PIE proceeding | |
| 49:1.0.1.1.30.18.43.19 | SECTION 40.397
| 40.397 When does the Director make a PIE decision | |
| 49:1.0.1.1.30.18.43.20 | SECTION 40.399
| 40.399 How does the Department notify service agents of its decision | |
| 49:1.0.1.1.30.18.43.21 | SECTION 40.401
| 40.401 How does the Department notify employers and the public about a PIE | |
| 49:1.0.1.1.30.18.43.22 | SECTION 40.403
| 40.403 Must a service agent notify its clients when the Department issues a PIE | |
| 49:1.0.1.1.30.18.43.23 | SECTION 40.405
| 40.405 May the Federal courts review PIE decisions | |
| 49:1.0.1.1.30.18.43.24 | SECTION 40.407
| 40.407 May a service agent ask to have a PIE reduced or terminated | |
| 49:1.0.1.1.30.18.43.25 | SECTION 40.409
| 40.409 What does the issuance of a PIE mean to transportation employers | |
| 49:1.0.1.1.30.18.43.26 | SECTION 40.411
| 40.411 What is the role of the DOT Inspector General's office | |
| 49:1.0.1.1.30.18.43.27 | SECTION 40.413
| 40.413 How are notices sent to service agents | |
| 49:1.0.1.1.30.19 | SUBPART 0
| | |
| 49:1.0.1.1.30.20.43.1.28 | APPENDIX Appendix A
| Appendix A to Part 40 - DOT Standards for Urine Collection Kits | |
| 49:1.0.1.1.30.20.43.1.29 | APPENDIX Appendix B
| Appendix B to Part 40 - DOT Drug-Testing Semi-Annual Laboratory Report to Employers | |
| 49:1.0.1.1.30.20.43.1.30 | APPENDIX Appendix C
| Appendix C to Part 40 - DOT Drug-Testing Semi-Annual Laboratory Report to DOT | |
| 49:1.0.1.1.30.20.43.1.31 | APPENDIX Appendix D
| Appendix D to Part 40 - Report Format: Split Specimen Failure To Reconfirm | |
| 49:1.0.1.1.30.20.43.1.32 | APPENDIX Appendix E
| Appendix E to Part 40 - SAP Equivalency Requirements for Certification Organizations | |
| 49:1.0.1.1.30.20.43.1.33 | APPENDIX Appendix F
| Appendix F to Part 40 - Drug and Alcohol Testing Information that C/TPAs May Transmit to Employers | |
| 49:1.0.1.1.30.20.43.1.34 | APPENDIX Appendix G
| Appendix G to Part 40 - Alcohol Testing Form | |
| 49:1.0.1.1.30.20.43.1.35 | APPENDIX Appendix H
| Appendix H to Part 40 - DOT Drug and Alcohol Testing Management Information System (MIS) Data Collection Form | |